[6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid

C29H27BClN7O4 — CID 90365198

IUPAC[6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid
SMILESCOc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCc1ccc3nc(B(O)O)[nH]c3c1)c1nnc(C)n1-2
InChIInChI=1S/C29H27BClN7O4/c1-16-36-37-28-24(15-26(39)32-12-11-17-3-9-22-23(13-17)35-29(34-22)30(40)41)33-27(18-4-6-19(31)7-5-18)21-14-20(42-2)8-10-25(21)38(16)28/h3-10,13-14,24,40-41H,11-12,15H2,1-2H3,(H,32,39)(H,34,35)/t24-/m0/s1
InChIKeyHWYVURSNUFAHCX-DEOSSOPVSA-N
MW583.85 g/mol
LogP2.43
Rot. Bonds8

About [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid

[6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid (PubChem CID 90365198) has the molecular formula C29H27BClN7O4 and a molecular weight of 583.85 g/mol. Its IUPAC name is [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid.

Molecular Properties

Compound Name[6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid
PubChem CID90365198
Molecular FormulaC29H27BClN7O4
Molecular Weight583.85 g/mol
Exact Mass583.19
IUPAC Name[6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid
SMILESCOc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCc1ccc3nc(B(O)O)[nH]c3c1)c1nnc(C)n1-2
InChIInChI=1S/C29H27BClN7O4/c1-16-36-37-28-24(15-26(39)32-12-11-17-3-9-22-23(13-17)35-29(34-22)30(40)41)33-27(18-4-6-19(31)7-5-18)21-14-20(42-2)8-10-25(21)38(16)28/h3-10,13-14,24,40-41H,11-12,15H2,1-2H3,(H,32,39)(H,34,35)/t24-/m0/s1
InChIKeyHWYVURSNUFAHCX-DEOSSOPVSA-N
XLogP2.43
TPSA150.54 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500583.85
LogP ≤ 52.43
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid?
The IUPAC name of [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid (CID 90365198) is [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid.
What is the SMILES notation for [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid?
The canonical SMILES for [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid is COc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCc1ccc3nc(B(O)O)[nH]c3c1)c1nnc(C)n1-2.
What is the InChIKey of [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid?
The InChIKey is HWYVURSNUFAHCX-DEOSSOPVSA-N. The full InChI is InChI=1S/C29H27BClN7O4/c1-16-36-37-28-24(15-26(39)32-12-11-17-3-9-22-23(13-17)35-29(34-22)30(40)41)33-27(18-4-6-19(31)7-5-18)21-14-20(42-2)8-10-25(21)38(16)28/h3-10,13-14,24,40-41H,11-12,15H2,1-2H3,(H,32,39)(H,34,35)/t24-/m0/s1.
What are the key properties of [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid?
[6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid has a molecular weight of 583.85 g/mol, XLogP of 2.43, 8 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [6-[2-[[2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-1H-benzimidazol-2-yl]boronic acid is sourced from PubChem (CID 90365198), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).